Quick Answer
IONIS PHARMACEUTICALS INC reported Stockholders Equity of $489.09 million for fiscal year 2025.
IONIS PHARMACEUTICALS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $489.09M | -16.9% |
| 2024 | $588.35M | +52.2% |
| 2023 | $386.69M | -32.5% |
| 2022 | $572.89M | -25.8% |
| 2021 | $771.74M | +3.8% |
| 2020 | $743.28M | -49.5% |
| 2019 | $1.47B | +40.4% |
| 2018 | $1.05B | +273.0% |
| 2017 | $281.01M | +182.2% |
| 2016 | $99.56M | -50.4% |
| 2015 | $200.79M | -22.1% |
| 2014 | $257.78M | -31.9% |
| 2013 | $378.39M | +107.0% |
| 2012 | $182.77M | +6.6% |
| 2011 | $171.43M | -29.9% |
| 2010 | $244.54M | -16.2% |
| 2009 | $291.72M | +97.9% |
| 2008 | $147.38M | +147.3% |
| 2007 | $59.59M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $617.97M | -6.7% | -2.2% |
| June 30, 2025 | $631.72M | +139.6% | +32.8% |
| March 31, 2025 | $475.73M | +60.4% | -19.1% |
| December 31, 2024 | $588.35M | +52.2% | -11.2% |
| September 30, 2024 | $662.47M | +110.0% | +151.2% |
| June 30, 2024 | $263.70M | -38.4% | -11.1% |
| March 31, 2024 | $296.51M | -39.1% | -23.3% |
| December 31, 2023 | $386.69M | -32.5% | +22.6% |
- IONIS PHARMACEUTICALS INC showed a decrease of -16.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, IONIS PHARMACEUTICALS INC’s stockholders equity has grown by 720.8% (from $59.59 million to $489.09 million).
- The most recent figure is from IONIS PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: